Are these high-flying ASX shares buys today?

Pro Medicus is one of the ASX shares that has been flying higher. Are they buys?

| More on:
asx investor daydreaming about US shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There is a small group of ASX shares that have performed really strongly for shareholders recently, delivering impressive operational results and market-beating share price growth.

However, whilst it's possible for some share prices to be good value, it is also possible that some excellent businesses to run ahead too hard.

So, after a strong run, are these two ASX shares worth looking at?

Pro Medicus Ltd (ASX: PME)

Pro Medicus describes itself as a leading healthcare informatics business. It provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups globally. It offers a "clinically rich" and highly scalable cloud platform that can be used for both public and private environments.

The Pro Medicus share price has soared 84% over the last year.

This ASX share has been winning many large contracts with healthcare clients. One of the most recent wins was the 7-year, $40 million contract with Novant Health. Pro Medicus' Visage software will replace multiple picture archiving and communication systems (PACs).

Novant Health joined an increasing number of Visage clients that are opting for a fully cloud based solution.

Despite winning a number of contracts, Pro Medicus says that its pipeline remains strong in both North America and other regions. FY21 was a big year of growth – revenue rose 19.5% to $67.9 million, underlying profit before tax increased 41% to $42.6 million and the earnings before interest and tax (EBIT) margin improved to 63.2%.

Opinions are somewhat mixed on Pro Medicus. Morgans rates the ASX share as a hold, with a price target of $54.49.

However, Citi thinks Pro Medicus is a sell with a price target of just $45 – that's almost 30% lower than where it is now. It's concerned about cheaper competition in the future and that the market is being too bullish about the potential strength of the company's success.

Aussie Broadband Ltd (ASX: ABB)

This telecommunications business has also had a year strong year. Over the last 12 months it has gone up by 136%.

Aussie Broadband continues to see growth of its broadband user base.

At 30 September 2021 it had 445,780 broadband services. By 30 December 2021 it's expecting to have at least 482,495 services which includes expected organic net additions of at least 38,000. That's organic growth of at least 8.5% quarter on quarter.

A recent focus of both analysts and the company has been the expected acquisition of Over The Wire Holdings Ltd (ASX: OTW). This combination is predicted to deliver annual cost synergies of $8 million to $12 million within three years, ongoing capital expenditure savings and significant acceleration of capabilities of the group.

This proposed transaction, which will be funded by both cash and new shares, is expected to add to earnings per share (EPS) on both a pre and post synergy FY21 basis.

Ord Minnett is a fan of the deal, as it would grow the company's offering into other categories.  It rates Aussie Broadband as a buy, with a price target of $5.91.

Credit Suisse's price target of $5.40 also offers potential double upside, but the broker is only 'neutral' on the business.

Ord Minnett thinks that the Aussie Broadband share price is valued at 34x FY23's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Aussie Broadband Limited, Over The Wire Holdings Ltd, and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Aussie Broadband Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Broker looking at the share price.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Broker Notes

Guess which ASX 200 share offers 12% upside and a 4% dividend yield

Bell Potter just slapped a buy rating on this stock.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Broker Notes

Qantas or Telstra share price: Which will climb higher in 2024?

Let's see what top broker Goldman Sachs has to say about these ASX blue-chip stocks.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Small Cap Shares

3 small-cap ASX shares with 'long runways for growth'

DNR's Sam Twidale reckons investors could do worse than buy these guys for the long run.

Read more »

Woman using laptop for job search
Investing Strategies

2 ASX 200 shares to buy for 'strong growth' at decent prices right now

Searching for a bargain? Here's a pair that Catapult's Dylan Evans has his eyes on at the moment.

Read more »

A Paladin Energy miner wearing a hard hat and protective gear stands in front of a large mining truck and smiles to the camera.
Energy Shares

Uranium is set to boom, and this is the 'premium' ASX stock to buy

Shaw and Partners' Jed Richards reckons these are the shares to buy for the nuclear energy theme.

Read more »

female in hard hat crosses fingers
Investing Strategies

The ASX 200 stock that could get second time lucky

These shares have failed to impress in 2024, but many experts believe it's a bargain buy.

Read more »